Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL. - Wikidata - wikimedia - TriplyDB

Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.

Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.

http://www.wikidata.org/entity/Q42115123

about

Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies DangER: protein ovERload. Targeting protein degradation to treat myeloma Xenobiotic perturbation of ER stress and the unfolded protein response First siRNA library screening in hard-to-transfect HUVEC cells.Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells.Endoplasmic reticulum stress and cancer.Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabine A review of the mammalian unfolded protein response.The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib Toxicogenomics of endoplasmic reticulum stress inducer tunicamycin in the small intestine and liver of Nrf2 knockout and C57BL/6J mice.Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance.miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A.Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.Endoplasmic reticulum stress in disease pathogenesis Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA.The molecular characterization and clinical management of multiple myeloma in the post-genome era.Endoplasmic reticulum stress: its role in disease and novel prospects for therapy.SAC1 lipid phosphatase and growth control of the secretory pathway.ER-Golgi network--a future target for anti-cancer therapy.Chip-based dynamic real-time quantification of drug-induced cytotoxicity in human tumor cells Activation of the EIF2α/ATF4 and ATF6 Pathways in DU-145 Cells by Boric Acid at the Concentration Reported in Men at the US Mean Boron Intake.The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus.Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy.Risk Stratification in Multiple Myeloma.Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.Brefeldin a induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits focal adhesion kinase-mediated cell invasion.Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling.Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma.Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice.Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments.The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomib Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma.γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas.The phospholipase DDHD1 as a new target in colorectal cancer therapy.Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review

P2860

Q24322060-A60BAF73-2FA7-4F8E-AE03-DE8301510C0B Q26825417-D295F4F0-0AC3-452C-97F0-242CB8D8897D Q26998690-C82387B0-07BE-4AEB-B7ED-E4380F4C655F Q33632140-0D819D86-BA75-4DE2-AD36-898774444D7D Q34104084-840D1957-006F-4284-BE37-08EE37F13F34 Q34376123-FABAECD5-C2AC-487E-B94D-47107CCF9FD1 Q34508337-8C2EA05C-D3BA-49C5-9A9B-01BB5AE64FE0 Q34979606-13EBE879-CF85-4C26-BF73-B21AAF2587E3 Q35354864-F75A08C9-9955-4447-B930-14377EABE080 Q35377275-9B009BDD-B48C-4F16-A30A-4F3984B8B4D5 Q35740930-CEE454EA-37F7-4A43-93E2-3325112AEEDF Q35850687-A87D9E18-5AC4-4666-8EEB-04D58E7F5BD8 Q35932634-912A1996-C52F-4470-AE44-1845FF557C27 Q36164893-50E48223-0890-4A17-82C1-20FCA5323BCB Q36842308-718841DF-2B99-4101-848F-F35002D97C14 Q36915932-DA807A08-5F40-431F-B84B-D3AB4625F14B Q36939043-4FE6735F-D730-4B3F-8D2E-16B18C616F2B Q37288073-0F84AB0C-9596-42AC-A51F-86ED1D1BE6AA Q37350551-CA6F59EA-B500-4FC7-92C6-6FA7E107F6E7 Q37359410-3DCC43AD-F918-4653-AAC7-7D6DDA2782BA Q37688453-01C9CBC1-B34B-4B04-AB47-0A0E35D332A6 Q37692124-28015714-3AB9-432B-9246-A724D32AA63B Q37946246-7A6A55BF-575C-434C-9F98-EC5951DB9A77 Q38315523-60DBB8C9-B19F-4584-B665-0064DC85689C Q38623057-65982DD3-F53D-46E5-929E-81829F7AC1E9 Q38736249-A49291A3-09BE-46CC-986C-E3D9425A01BE Q38908575-66B57C38-667E-492A-9A81-82B643B632E2 Q39130477-407380AC-2838-4878-B9BA-04A268EE7BBB Q39799320-4B635503-CF51-4103-A9D7-9DA25DE80878 Q40140755-2A30A748-5070-4F94-A136-8616A16BBE26 Q40307342-EF4F5383-F23E-4032-9149-203F960FC3C8 Q41701047-68DCA91C-B69A-47EB-A429-168537F116F8 Q41786115-31E7B563-807F-46D9-9B63-DB95F12C5134 Q41790227-E210E787-30D2-41EE-B858-AA1EC76E691D Q42037254-302AD79D-9304-49B8-A55F-7EA90556715C Q44623962-917334E9-D08B-49E3-BD7B-50A2C860C265 Q46067297-71EC2EDA-DAAD-4F97-9FF0-B85AB9EBEAE8 Q47266341-B7FA195B-B00D-4903-8B57-BCE255EC92C0 Q55046833-777153B9-5E70-47B8-82BC-49F2262F9764 Q58800467-3AC048B8-72E5-428F-8234-575203CF6CB2

P2860

Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.

http://www.wikidata.org/entity/Q42115123

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Targeting endoplasmic reticulu ...... fludarabine resistance in CLL.

@en

Targeting endoplasmic reticulu ...... fludarabine resistance in CLL.

@nl

type

label

Targeting endoplasmic reticulu ...... fludarabine resistance in CLL.

@en

Targeting endoplasmic reticulu ...... fludarabine resistance in CLL.

@nl

prefLabel

Targeting endoplasmic reticulu ...... fludarabine resistance in CLL.

@en

Targeting endoplasmic reticulu ...... fludarabine resistance in CLL.

@nl

P1433

Q42115123-C45B2751-AA17-47AC-A4FC-F33CF328FA2F

P1476

Q42115123-1A042109-3997-43AD-9EE1-FADA13D2CE6D

P2093

Q42115123-08341689-D8F8-4331-95BE-3B816FB9409A

Q42115123-27AA6D46-CFE7-4A4E-BD49-CA79B19646FB

Q42115123-349C363E-1C63-454E-A18B-C3D70A9459CE

Q42115123-78F427AB-AC82-42AB-9215-F6CA6E0B6A3F

Q42115123-C9C225B0-F7B6-4B80-B232-F5BC1DBFA74C

Q42115123-E9B3122F-F3D4-44B6-A8B4-A39BB06ADBD1

P2860

Q42115123-06AE6F2B-02BC-400B-907C-B215EA55149D

Q42115123-09EFD99B-7B8C-4DCC-B391-34960E862482

Q42115123-0FCF202F-8944-4634-9031-9A399C03FFAC

Q42115123-1990DA71-6A7E-4107-A2C8-180D8BBCE265

Q42115123-1D3194A9-F4FC-4365-BC28-17B37985D132

Q42115123-1EE3D01C-C30D-4AF0-8F7D-D474DE253E18

Q42115123-2310F109-F2FA-48B3-9C6D-ED27DA626920

Q42115123-2601E19B-E0F4-4529-8690-311D435F51B3

Q42115123-29FBDE9A-F90B-4BC8-9FB8-CF9DC58639E0

Q42115123-2B255C27-5515-4DEA-ABEC-AB645CE8BA3E

P304

Q42115123-D1A6AAFC-3B6A-4C45-9D24-A146BB478896

P31

Q42115123-D94509B4-E47C-476A-88E5-59A5174E98E0

P356

Q42115123-A8577B00-3DE0-42B3-929A-5190D31BB3E2

P407

Q42115123-D4A58715-D1F9-4D71-AB1E-7E5E9AD4792D

P433

Q42115123-50E40EFA-A3A6-4BA7-A1F4-2230BBBC561D

P478

Q42115123-902CC70F-0DE5-40A0-8B8E-34D6A67BCA63

P50

Q42115123-6E093511-7DDA-4166-BE7C-B40A626F2CFD

P577

Q42115123-091F530A-5048-4F0F-A816-BACE8A203C9D

P5875

Q42115123-A0492FFE-70B4-4605-82B0-89875F1225E0

P698

Q42115123-99443F7A-6866-4FC7-A7E6-119D48904E35

P921

Q42115123-8352489B-8038-4E28-B84F-78A4C8181A13

P932

Q42115123-3A7DC543-D75E-4490-95A4-3B6F4D76ECD3

P356

BLOOD-2005-05-1923

P1433

P1476

Targeting endoplasmic reticulu ...... fludarabine resistance in CLL.

@en

P2093

David J McConkey

http://www.w3.org/2001/XMLSchema#string

Jennifer S Carew

http://www.w3.org/2001/XMLSchema#string

Kenneth Dunner

http://www.w3.org/2001/XMLSchema#string

Peng Huang

http://www.w3.org/2001/XMLSchema#string

Steffan T Nawrocki

http://www.w3.org/2001/XMLSchema#string

Yelena V Krupnik

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma cell differentiation requires the transcription factor XBP-1

The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress

Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase

Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors

Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

B-cell chronic lymphocytic leukemia: a bird of a different feather

IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA

TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1

Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1

P304

222-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-05-1923

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Keating

P577

2005-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7616244

http://www.w3.org/2001/XMLSchema#string

P698

16144803

http://www.w3.org/2001/XMLSchema#string

P921

endoplasmic reticulum

P932

1895341

http://www.w3.org/2001/XMLSchema#string